Rockwell Medical (RMTI) Depreciation & Amortization (CF) (2010 - 2026)
Rockwell Medical's (RMTI) quarterly Depreciation & Amortization (CF) came in at $492000.0 in Q2 2026, down 12.61% on a YoY basis from $563000.0 in Q2 2025, and down 3.72% quarter-over-quarter from $511000.0 in Q1 2026.
Powered by 
Analysis
Rockwell Medical (RMTI) Depreciation & Amortization (CF) (2010 - 2026) Analysis & Trends
Rockwell Medical (RMTI) has reported Depreciation & Amortization (CF) for 17 consecutive years, with $492000.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Depreciation & Amortization (CF) fell 12.61% year-over-year to $492000.0; the trailing twelve-month figure through Jun 2026 stood at $2.1 million (down 4.34% YoY), and the FY2025 full-year result was $2.2 million, up 0.55% from the prior year.
- Depreciation & Amortization (CF) retreated to $492000.0 in Q2 2026 per RMTI's latest filing, from $511000.0 in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $564000.0 in Q3 2023 and bottomed at $138000.0 in Q1 2022.
- Historically, Depreciation & Amortization (CF) has averaged $410833.3 across 5 years, with a median of $541000.0 in 2024.
- The sharpest annual moves came in 2022 and 2023: Depreciation & Amortization (CF) tumbled 31.68% in 2022, then soared 294.41% in 2023.
- Over 5 years, Depreciation & Amortization (CF) stood at $154000.0 in 2022, then surged by 257.14% to $550000.0 in 2023, then slipped by 1.27% to $543000.0 in 2024, then rose by 0.55% to $546000.0 in 2025, then retreated by 9.89% to $492000.0 in 2026.
- According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $492000.0, $511000.0, and $546000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Becton Dickinson | 49.48 Bn | 48.62 Bn | 2.32 Bn | 564.00 Mn |
| 2 | Medline | 29.24 Bn | 26.56 Bn | 2.22 Bn | 256.00 Mn |
| 3 | West Pharmaceutical Services | 23.94 Bn | 23.51 Bn | 329.20 Mn | - |
| 4 | Baxter International | 12.66 Bn | 10.51 Bn | 1.03 Bn | 239.00 Mn |
| 5 | Stevanato Group S.p.A | 5.51 Bn | 5.40 Bn | 100.91 Mn | 24.51 Mn |
| 6 | Acme United | 233.67 Mn | 228.63 Mn | 26.69 Mn | 1.95 Mn |
| 7 | Rockwell Medical | 31.87 Mn | 7.07 Mn | 3.24 Mn | 492,000.00 |
| 8 | Retractable Technologies | 21.39 Mn | -18.48 Mn | 190,852.00 | 1.90 Mn |
| 9 | United Health Products | 9.09 Mn | 9.06 Mn | - | 1,012.00 |
| 10 | Cuprina Holdings (Cayman) | 7.45 Mn | 4.33 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 492,000.00 |
| Mar 31, 2026 | 511,000.00 |
| Dec 31, 2025 | 546,000.00 |
| Sep 30, 2025 | 544,000.00 |
| Jun 30, 2025 | 563,000.00 |
| Mar 31, 2025 | 539,000.00 |
| Dec 31, 2024 | 543,000.00 |
| Sep 30, 2024 | 543,000.00 |
| Jun 30, 2024 | 549,000.00 |
| Mar 31, 2024 | 545,000.00 |
| Dec 31, 2023 | 550,000.00 |
| Sep 30, 2023 | 564,000.00 |
| Jun 30, 2023 | 170,000.00 |
| Mar 31, 2023 | 160,000.00 |
| Dec 31, 2022 | 154,000.00 |
| Sep 30, 2022 | 143,000.00 |
| Jun 30, 2022 | 141,000.00 |
| Mar 31, 2022 | 138,000.00 |
| Dec 31, 2021 | 133,000.00 |
| Sep 30, 2021 | 150,000.00 |